PCM
BTMD icon

Penserra Capital Management’s Biote Corp BTMD Stock Holding History

Penserra Capital Management’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,433
Closed -$12K – 1007
2022
Q2 		$12K Buy
3,433
+169
+5% +$1.33K ﹤0.01% 1199
2022
Q1 		$32K Buy
+3,264
New +$32.1K ﹤0.01% 1119

Other funds holding BTMD

CM
Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

Penserra Capital Management's BTMD Position: Q3 2022 in Review

Penserra Capital Management sold out of Biote Corp (BTMD) in Q3 2022, closing a stake of 3,433 shares — an estimated $12K sold.

Penserra Capital Management first reported a position in BTMD in Q1 2022 and held it in 2 quarters. The position peaked at $32K in Q1 2022. 16 funds tracked by Wall St. Rank hold BTMD as of Q3 2022.

  • Penserra Capital Management reported no remaining Biote Corp position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 3,433 Biote Corp shares in Q3 2022, an estimated $12K.
  • Penserra Capital Management first reported a position in Biote Corp in Q1 2022 and held it in 2 quarters.
  • Penserra Capital Management's Biote Corp position peaked at $32K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Biote Corp as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.